A pproximately 795 000 strokes occur annually in the United States, and stroke remains a leading cause of major disability. 1 Ischemic stroke accounts for ≈85% of cases, whereas the remaining 15% are attributable to hemorrhagic pathogeneses. Despite increased public awareness, improved prehospital triage and a greater focus on systems of care, intravenous tissue-type plasminogen activator, and endovascular intervention remain underutilized. 2 Recent advances in endovascular technology, coupled with the positive results of at least 5 major clinical trials, support the efficacy of mechanical thrombectomy as a treatment of ischemic stroke. [3] [4] [5] [6] These studies emphasize that interventional capabilities are an essential element of stroke care. Before the completion of these interventional trials, several simultaneous efforts arose to provide a method of certifying institutions as being optimized for advanced cerebrovascular care, and these efforts were inclusive of ischemic and hemorrhagic disease. It is in the spirit of constant iterative improvement that the authors of this article call for a refinement of the requirements for the certification of hospitals as comprehensive stroke centers (CSCs).
The certification process has the potential to serve an important function in improving the quality of care and patient outcomes by establishing criteria for certification of stroke centers. The Cerebrovascular Coalition (CVC), which represents all neuroscience-based physician professional societies in the United States (CVC member organizations include the American Academy of Neurology, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Society of Vascular and Interventional Neurology, American Society of Neuroradiology, and the Society of NeuroInterventional Surgery) involved in the care of patients with acute stroke, embraces and applauds the need for greater access to acute stroke therapy. The CVC thinks that, in principle, a certification process for stroke centers can have a positive impact on patient care and outcomes.
Current Certification Paradigms
The Joint Commission (TJC), in partnership with the American Heart Association (AHA), has developed an evolving tiered stroke center certification system. Most importantly, a Primary Stroke Center, the first type of center designation developed, is intended to identify hospitals able to care for patients with acute stroke and administer intravenous tissue-type plasminogen activator in a timely fashion to eligible patients. In an effort to move beyond these requirements, in 2012, the AHA and TJC developed an additional level of certification-designating a hospital as a CSC. Such certification is meant to reflect the capacity to provide advanced stroke care for patients with both ischemic and hemorrhagic stroke. Appropriate for these critically ill patients, CSC certification has rigorous requirements, including the availability of resources and subspecialty expertise relevant to complex ischemic and hemorrhagic stroke care. These requirements include the ability to provide endovascular intervention for the treatment of both ischemic stroke and aneurysmal subarachnoid hemorrhage (aSAH). The AHA/TJC has more recently created another designation
Procedural Requirements and Certification Paradigms for Stroke Care Delivery
Stroke October 2017
status-one for acute stroke-ready hospitals, which often do not have specialized stroke care professionals or acute stroke care units. These hospitals often transfer patients with acute stroke to a higher tier institution. At least 2 other certifying bodies are currently administering additional stroke center certification programs with somewhat differing criteria: Det Norske Veritas and Healthcare Facilities Accreditation Program. This had led to confusion among hospitals and physician professional societies on the certification process. [7] [8] [9] [10] Some authors have compared the efforts to certify stroke centers to the currently available verification system applied to trauma centers, led by the American College of Surgeons. 11 The CVC thinks that such comparisons have limited use and are not entirely appropriate. The American College of Surgeons verification is administered directly by a physician professional society, in contrast to the currently available stroke certification programs, with other entities overseeing the certification process. The CVC is concerned that the limited involvement of physician professional societies in stroke center certification may reduce the full potential of the process to improve patient outcomes and ensure high-quality stroke.
aSAH and CSC Certification
The CVC thinks that in the interest of the safest and highest quality care for patients with aSAH, the requirements for a CSC to care for these patients need further definition. Criteria for TJC CSC certification reflect the hospital's capacity to provide cerebrovascular neurosurgical expertise. Such expertise, however, is not clearly defined but does imply the ability to care for patients with ischemic stroke requiring neurosurgical intervention (eg, carotid endarterectomy and decompressive hemicraniectomy), as well as the ability to treat aneurysms with surgical clipping. Current requirements do little to ensure that such expertise is in fact available.
Although patients with aSAH represent only 5% of acute stroke admissions, the sequelae of this type of stroke (eg, vasospasm and delayed ischemic neurological deficits) are devastating and continue to result in high rates of morbidity and mortality despite advances in surgical, endovascular, and critical care. 12 Optimal care of these critically ill patients requires intensive resources and subspecialized cerebrovascular surgical expertise, which is often unavailable at lowvolume centers. In addition, although hemorrhages related to ruptured arteriovenous malformations and other structural vascular causes are even less common, treatment of these cerebrovascular pathologies is even more demanding of endovascular and open cerebrovascular surgical expertise.
The current AHA/TJC minimum requirements for aSAH care include an annual volume of 15 aneurysm clippings or coilings per year and management of 20 total aSAHs per year. 13 The CVC thinks these numbers are inadequate to ensure the highest possible level of care for these patients. There has long been evident a clear relationship between procedural volume and improved outcomes in many disease processes, including coronary intervention for acute myocardial infarction, trauma, and aSAH.
14-21 The AHA guidelines for the management of aSAH recommended consideration for transfer of patients with aSAH from low-volume hospitals (eg, <10 aSAH cases per year) to high-volume centers (eg, >35 aSAH cases per year) with experienced cerebrovascular surgeons. 22 Within the realm of neurointerventional procedures for acute stroke, there have been recommendations for minimum volumes of 25 to 30 procedures annually to maintain competency. 23 The Society of Neurological Surgeons through its Committee for Advanced Specialty Training has, in conjunction with representatives of the 3 societies that represent the majority of neuroendovascular practitioners (American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Cerebrovascular Section, Society of NeuroInterventional Surgery, and Society of Vascular and Interventional Neurology), defined training standards for certification in neuroendovascular surgery. 24 These standards include a minimum of 250 interventional procedures, including the treatment of 40 aneurysms as the primary operator. 25 The Society of Neurological Surgeons is currently in the process of defining similar case thresholds for achieving certification recognizing expertise in cerebrovascular microsurgery. The lack of inclusion of higher volume standards to the treatment of aSAH has been largely based on concerns on the number of centers, which may not qualify under more stringent requirements, and the view that evidence linking outcomes to procedural volume is inadequate. In its analysis, TJC noted that modestly increasing the volume requirements to those proposed by the CVC and TAP (ie, 10 clippings per year and 20 coilings per year, with 35 aSAH cases annually) would result in 21% of current CSCs losing certification, which would increase the need to transfer patients to facilities with higher volumes resulting in unspecified negative consequences. Additional information on the potential negative consequences of a need to increase patient transfers and increased travel times is in fact unclear, and methods to determine impact on patient outcomes should be developed.
The CVC thinks strategies can be developed that would ensure the safest and highest quality care for patients with aSAH and other causes of hemorrhagic stroke without negatively impacting access to advanced stroke care for the more prevalent ischemic stroke population. One possibility is an additional designation for a CSC, such as a CSC with Advanced Vascular Capability, which would require higher volume of patients with aSAH and more rigorous requirements for cerebrovascular neurosurgery. Of course, a tiered CSC system would need to include contingencies for dealing with hemorrhagic stroke at all hospitals.
Given this background, the CVC would strongly advocate for clarity on the provider training necessary to satisfy the requirements for cerebrovascular neurosurgical expertise. Currently, there is no specific CSC requirement on neurosurgical training and technical expertise required to care for patients with complex cerebrovascular disorders. Although there is no formal accreditation by the American Board of Neurological Surgery as a cerebrovascular neurosurgeon, the Society of Neurological Surgeons and the American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Cerebrovascular Section have been developing practice standards that define this expertise. The CVC strongly urges TJC to work in close collaboration with the Society of Neurological Surgeons and American Association of Neurological Surgeons/Congress of Neurological Surgeons Joint Cerebrovascular Section to include these standards in the current CSC certification process. Although the CVC has not engaged with other stroke certifying organizations, such as Det Norske Veritas Germanischer Lloyd (DNV GL) or Healthcare Facilities Accreditation Program, in improving their certification requirements along these guidelines and training recommendations, such engagement is planned. These principles are not unique to aSAH. The CVC recommends that TJC and other certifying bodies should consult the CVC to clarify the level of physician expertise providing acute ischemic stroke, neurocritical, neurointerventional, and open neurosurgical care.
Conclusions
The overwhelming results from recent endovascular mechanical thrombectomy intervention for acute stroke trials are to be applauded as game-changing advances in stroke care; increased focus on regionalization and stroke systems of care is appropriate. Interventional competency for both ischemic and hemorrhagic stroke is now an integral aspect of stroke care. It is the intent of the CVC to work with TJC/AHA to develop evidence-based stroke center certification criteria that includes more specific requirements for cerebrovascular neurosurgical expertise, which will improve outcomes in our patients with ischemic and hemorrhagic strokes. 
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